12.14.19 Elin said: Such a great and helpful post
According to the FDA's press release it agreed to approve the drug for obesity based on three randomised, double-blind, placebo-controlled trials during which more than 2,600 patients received Wegovy for up to 68 weeks and more than 1,500 patients received placebo (US FDA 2021)
But its still important to get checked out if you see it
Please note that among the FDA-approved medications, Wegovy is approved for weight management while Ozempic is approved for T-2 diabetes management
We hold Semaglutide in permanent UK stock so laboratory orders are never blocked by supplier backorder, and every dispatched vial is traceable to a retained reference sample kept for a minimum of twelve months
It allows for the examination of the entire sequencefrom the administration of GH, to receptor activation, and finally to the sustained growth factor signaling that influences practical outcomes like protein synthesis and tissue repair